Best MRI of One Area Doctors Abroad

Dr. Ali Ihsan Anadolulu leads gastrointestinal care at Central Hospital. He uses MRI of one area to study complex digestive and pelvic floor disorders.

• Specializes in gastroenterology and internal medicine at Istanbul University Cerrahpaşa Faculty of Medicine
• Expert in motility disorders – conditions affecting how food moves through the digestive system
• Focuses on minimally invasive pediatric surgery and pelvic floor disorders
• Author of multiple medical textbooks and scientific publications on digestive health

Dr. Wangrattanapranee is a fellowship-trained orthopedic surgeon at LUX KOR Hospital. He specializes in hand surgery and microsurgery during musculoskeletal MRI evaluations.

• Completed a specialized fellowship in hand surgery and microsurgery at Mahidol University
• Expertise in orthopedic trauma for urgent bone and joint imaging needs
• Trained at Siriraj Hospital – Thailand's oldest and largest medical center
• Focuses on precise diagnostics for complex hand and wrist conditions

Associate Professor Burak Gunaydin is a highly recognized orthopedic specialist at Optimed International Hospital. He has developed a new MRI method specifically designed to improve the accuracy of anterior cruciate ligament (ACL) tear diagnosis.

• Published research on advanced MRI techniques using maximum knee flexion in the prone position
• Expertise in orthopedic oncology, prosthetic surgery, and complex fracture treatments
• Recipient of the Akif Şakir Şakar Science Award for excellence in clinical research
• Member of the Turkish Sports Injury Arthroscopy and Knee Surgery Association (TUSYAD)

Dr. Sven Propson is the chief physician of pediatrics at the Academic Hospital Solingen. He is a recognized expert in neonatology and pediatric cardiology in Germany and Europe. He specializes in intensive care and emergency medicine for infants and adolescents. Dr. Propson conducts research to implement the latest pediatric treatments in his department.

• Served as a lead physician at the Leverkusen Clinic for over 10 years.
• Managed the pediatric intensive care unit at a major German medical center.
• Is an expert reviewer for international scientific journals.
• Member of the German Association of Physicians.

Dr. Stanislaw Klosinski is a specialist in orthopedics and musculoskeletal traumatology. He graduated from the Poznan University of Medical Sciences in 2013. He earned a PhD in medical sciences in 2021. He completed his residency at the Medical University of Łódź. He is a staff surgeon and lecturer at the Central Teaching Hospital (CSK CKD). He performs advanced procedures.

He treats adults and children. He offers both non-surgical care and modern surgical methods. He provides bilingual consultations. His clinical focus includes foot and ankle deformities; knee and hip osteoarthritis; meniscus and ligament injuries; hand and arm overuse syndromes; trauma and fractures; and pediatric hip dysplasia.

Dr. Rattalerk Arunakul is a spinal surgeon at KDMS Specialized Orthopedic Hospital in Bangkok. He specializes in endoscopic and reconstructive spine surgery for adults and children. Dr. Arunakul completed fellowships at Yale School of Medicine and UC San Diego. He uses minimally invasive techniques to treat scoliosis and osteoporosis.

• Completed clinical training in spinal surgery at Yale School of Medicine.
• Served as an International Fellow in Pediatric Spinal Deformity at UC San Diego.
• Performs endoscopic discectomy and minimally invasive fusion surgery.
• Practices at Thailand's first dedicated AACI-accredited orthopedic hospital.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Burcin Kececi is an orthopedic surgeon at Medical Point İzmir Hospital. He specializes in orthopedic oncology, pediatric orthopedics, and complex bone tumors. Dr. Kececi completed specialized training in France focusing on knee, hip, and sports injuries. He also holds rare expertise in minimally invasive hip surgery techniques.

• Specializes in treating bone metastases and soft tissue tumors.
• Performs limb lengthening, tendon transfers, and joint prosthesis replacements.
• Member of the International Society of Limb Salvage (ISOLS).
• Former board member of the Turkish society TOTBİD.

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

Dr. med. univ. Negar Fakhrai is a radiology specialist at JUVENIS Medical Center in Vienna. She performs diagnostic ultrasound. She has more than 20 years of experience in university, trauma, and private hospitals. She treats patients in German, English, Farsi, and French.

Education: MD, 2001. Her dissertation quantified coronary artery calcification with electron-beam computed tomography. Training in internal medicine and oncology at the Medical University of Vienna with CECOG (2001–2004). Radiology training at the University Clinic (2005–2013). Radiology specialist exam in 2010.

Career: Lorenz Böhler Trauma Hospital (2013–2021). Private clinics since 2016. Rudolfinerhaus (2021–2022). Independent since 2023, including Wiener Privatklinik. Joined JUVENIS in 03/2024. Strong focus on musculoskeletal imaging.

Awards/research: Investigator Award, University Clinic for Radiodiagnostics, Medical University of Vienna (2010). Publications in the American Journal of Neuroradiology, European Journal of Radiology, and Journal of Neuro-Oncology. Ultrasound: abdomen; vascular (carotids, deep leg veins); breast; thyroid/neck; muscles/joints; soft tissue; testes.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Prof. Dr. Hakan Levent Gül is a neurologist. He graduated from the Trakya University Faculty of Medicine in 1998. He completed his neurology residency at Dr. Lütfi Kırdar Kartal Training and Research Hospital. He later became an associate professor and then a professor. He also holds a second undergraduate degree in Healthcare Management.

He has worked as a neurologist and senior attending physician in public and private institutions. His expertise includes headache and dizziness, epilepsy, Parkinson’s disease, dementia, movement disorders, stroke, and sleep disorders. He provides neurological care at Moodist Hospital.

Professor Byung-in Lee is a neurologist and epilepsy specialist. He directs the Lee Byung-in Epilepsy Center at Myongji Hospital. He earned his MD at Yonsei University. He studied neuroscience at Indiana University. He completed a neurology residency at the University of Minnesota. He finished a Clinical Neurophysiology fellowship at the Cleveland Clinic.

He previously directed the Epilepsy Center at Inje Haeundae Paik Hospital. He also led the Neurology Center at Severance Hospital. He is Honorary President of the Korean Epilepsy Society. He is President of the Korean Neurological Association. His awards include the 2018 Distinguished Service Award from the Korean Epilepsy Society and the 2014 Songpa Medical Award. His research focuses on epilepsy and clinical neurophysiology. He has published many papers, including in Acta Neurologica Scandinavica (2020), Journal of Neurology (2020), and BMC Neurology (2019). He contributed to Clinical Epileptology and wrote chapters on epilepsy and antiepileptic drugs.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Dr. Bulent Erol is an orthopedic oncologist at VM Medical Park Pendik Hospital in Istanbul. He won first prize for orthopedic oncology at the National Turkish Orthopedic Congress. Dr. Erol completed his fellowship at the Children’s Hospital of Philadelphia. He specializes in bone tumors and complex pediatric orthopedic surgery.

• Completed a clinical visiting program at the Royal Orthopaedic Hospital in the UK.
• Winner of multiple Akif Şakir Şakar Scientific Awards for clinical and experimental studies.
• Member of the European Pediatric Orthopaedics Society.
• Treats complex bone injuries, fractures, and arthrosis using robotic-assisted techniques at a JCI-accredited facility.

Dr. Kim Jin Gu is a Korean orthopedic surgeon who specializes in knee surgery and sports medicine. He is the Medical Director and the Sports Medicine Center Director at Myongji Hospital. His main areas are ACL reconstruction, meniscus surgery and transplantation, knee arthroscopy, and knee replacement. He offers pre‑treatment online consultations for international patients.

In 2022 he surpassed 3,000 ACL reconstructions over more than 25 years of practice. He trained at the University of Pittsburgh. He introduced advanced ACL techniques. His team uses the CUVIS Joint robot for precise knee replacement. He serves as Vice President of the Korean Society of Sports Medicine. He is a council member of the Korean Knee Society and the Korean Arthroscopy Society. He serves on the editorial boards of the American Journal of Sports Medicine and Arthroscopy and Orthopedic Sports Medicine. His awards include Best Paper and Most Cited (Korean Knee Society), Best Paper (Korean Arthroscopy Society), and Best Doctor (Korean Athletic Trainers Association). He earned his MD from Seoul National University. He completed his MS and PhD at Inje University. He is the lead author of Knee Arthroscopy—Up‑to‑Date Guide (Springer).

Dr. Ercan Kocakoc is a prize-winning radiologist at Medical Park Bahcelievler Hospital in Istanbul. He won 1st Prize at the 2009 ESGAR congress for clinical cases. Dr. Kocakoc specializes in interventional radiology and advanced body imaging. He completed a research fellowship at the University Hospital of Cleveland in the USA.

• Performs liver chemoembolization and radioembolization for cancer patients.
• Treats urological conditions through procedures like varicocele embolization.
• Held former chairmanship roles at Bezmialem Vakif and Yeditepe Universities.
• Fellow of the European Society of Gastrointestinal and Abdominal Radiology.

The doctor is an experienced neurosurgeon with an extensive background in both military and civilian medical practice. Holding a medical degree from the GATA School of Military Medicine and a specialization in neurosurgery, the doctor has served in various capacities, including as a Chief of Neurosurgery Clinic and a Chief Assistant in the Department of Neurosurgery. The doctor also holds a Master’s degree in Hospital and Health Institutions Management.

With a strong academic presence, the doctor has served as a lecturer and faculty member at Altınbaş University. Clinical expertise spans microsurgery, spine surgery, and peripheral nerve surgery, supported by numerous certifications in advanced cardiac life support and specialized surgical techniques. The doctor is a prolific researcher with extensive publications in neurosurgical journals.

Dr. Yang Se Yeon is a neurosurgeon and Head of the Department of Neurosurgery at Naeun Hospital. He specializes in cerebral infarction, cerebral hemorrhage, cerebral aneurysm, moyamoya disease, carotid artery stenosis, vascular dizziness, and head trauma.

He graduated from The Catholic University of Korea College of Medicine. He also earned a Master’s in Medicine there. He completed an internship and a neurosurgery residency at Catholic Medical Center. He then completed a clinical fellowship and served as a clinical assistant professor at Uijeongbu St. Mary’s Hospital.

He has served as a staff neurosurgeon at the Northern Gyeonggi Regional Trauma Center. He was also Head of Neurosurgery at G-SAM Hospital.